SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CVTX - CV Therapeutics, Inc. -- Ignore unavailable to you. Want to Upgrade?


To: mopgcw who wrote (271)8/4/2006 8:13:41 AM
From: rkrw  Read Replies (1) | Respond to of 411
 
Don't think a lot of people on the street aren't enjoying watching Lange squirm.

Eyeballing the numbers it looks like they'll need somewhere around $400M in sales to breakeven at current spend rates and the balance sheet is awful, $400M in debt and burning nearly $1M/day. They badly need the next sets of ranexa data to hit hr's.